Applied BioCode Corporation (6598.TW) TAI

Currency In TWD

Key Executives

Name	Title	Pay	Year Born
Winston Z.	Founder, Chief Executive Officer, President & Director	42,000	N/A
Jaca Liang-Kai Huang	Chief Financial Officer & Corporate Governance Officer	6.17M	N/A
Jim Leigh	Senior Vice President of Sales	0	N/A
Ingrid Joseph	Administration Division Director	0	N/A
Zhao Gu Chen	Accounting Director	0	N/A
Ruei-E Tang	Administration Division Director	0	N/A
Parisa Hanachi	Vice President of Marketing	0	N/A
Yu-Tsung Chou	Chief Information Officer	0	N/A
Beth Laderman	Chief Scientific Officer	0	N/A

Name

Title

Pay

Year Born

Winston Z.

Founder, Chief Executive Officer, President & Director

42,000

N/A

Jaca Liang-Kai Huang

Chief Financial Officer & Corporate Governance Officer

6.17M

N/A

Jim Leigh

Senior Vice President of Sales

N/A

Ingrid Joseph

Administration Division Director

N/A

Zhao Gu Chen

Accounting Director

N/A

Ruei-E Tang

Administration Division Director

N/A

Parisa Hanachi

Vice President of Marketing

N/A

Yu-Tsung Chou

Chief Information Officer

N/A

Beth Laderman

Chief Scientific Officer

N/A

Description

Applied BioCode Corporation specializes in the complete lifecycle—from design and development to manufacturing and commercialization—of multiplex diagnostic testing solutions tailored for the In-Vitro Diagnostics (IVD) market. Among its key offerings are two sophisticated systems: the BioCode MDx 3000, an automated molecular diagnostics platform that streamlines PCR amplification, hybridization, and detection steps; and the BioCode 2500 analyzer, specifically engineered to read barcoded magnetic beads (BMBs) and display their unique identification along with fluorescence intensity. The company also boasts an extensive portfolio of diagnostic assays, including the BioCode SARS-CoV-2 Assay, a high-throughput, automated nucleic acid multiplex test for detecting SARS-CoV-2 genetic material in nasopharyngeal swabs. Other panels comprise BioCode Respiratory Pathogen Panels, capable of simultaneously identifying and differentiating seventeen distinct respiratory pathogens in nasopharyngeal samples, and BioCode gastrointestinal (GI) pathogen panels, which target prevalent GI pathogens such as viruses, bacteria, and parasites responsible for infectious diarrheal diseases. An expanding pipeline of MDx assays for various molecular tests is also under development. Beyond these, Applied BioCode provides specialized reagents like analyte-specific reagents for fungal pathogens, and multiplex kits for human cytokines and chemokines, vital for biomarker identification. For research flexibility, they offer premixed and customizable multiplex kits for mouse models, alongside similar cytokine/chemokine multiplex kits for rat, monkey, canine, and non-human primate studies. Rounding out its comprehensive services, the company supplies its proprietary BMBs, calibration beads, and coupling kits for a wide array of bioassay applications. They also offer ELISA (Enzyme-Linked Immunosorbent Assay), a method for the precise quantification of drug, protein, or antibody levels in biological samples such as cell lysates or serum, in addition to providing full-spectrum assay development services. Applied BioCode Corporation is headquartered in Santa Fe Springs, California.